Risk assessment found that there was not a significant risk for HSP if the patient is with TT genotype (OR: 1.11, 95% CI: 0.61-2.03) or with CT genotype (OR: 0.82, 95% CI: 0.53-1.26). Patients with the 2767 A allele showed higher proteinuria and creatinine levels at follow-up.31 Yet, proteinuria and the serum level of creatinine in the acute stage of HSP had no relationship with IL-8 gene +781C/T polymorphism in this study. The TT genotype frequencies of the IL-8 gene +781C/T polymorphism in HSP patients with renal, GI and arthritis manifestations were 17.4%, 15.7%, and 18.6%, respectively. No significant differences in the distribution of genotype frequencies of IL-8 gene +781 C/T polymorphism were found between the controls and HSP patient subgroups. IL-8 gene +781 C/T polymorphism did not seem to have an impact on the development of renal, GI and arthritis manifestations of the
Risk assessment found that there was not a significant risk for HSP if the patient is with TT genotype (OR: 1.11, 95% CI: 0.61-2.03) or with CT genotype (OR: 0.82, 95% CI: 0.53-1.26). Patients with the 2767 A allele showed higher proteinuria and creatinine levels at follow-up.31 Yet, proteinuria and the serum level of creatinine in the acute stage of HSP had no relationship with IL-8 gene +781C/T polymorphism in this study. The TT genotype frequencies of the IL-8 gene +781C/T polymorphism in HSP patients with renal, GI and arthritis manifestations were 17.4%, 15.7%, and 18.6%, respectively. No significant differences in the distribution of genotype frequencies of IL-8 gene +781 C/T polymorphism were found between the controls and HSP patient subgroups. IL-8 gene +781 C/T polymorphism did not seem to have an impact on the development of renal, GI and arthritis manifestations of the